Acurx Pharmaceuticals, Inc. Common Stock (ACXP) is a publicly traded Healthcare sector company. As of May 21, 2026, ACXP trades at $1.89 with a market cap of $7.74M and a P/E ratio of -0.35. ACXP moved +0.00% today. Year to date, ACXP is -33.92%; over the trailing twelve months it is -77.18%. Its 52-week range spans $1.33 to $44.00. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces ACXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACXP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACXP recently traded at $1.89. Market cap is $7.74M. P/E ratio is -0.35. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.89 |
| Market Cap | $7.74M |
| P/E Ratio | -0.35 |
| EPS | $-5.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.00 |
| 52-Week Low | $1.33 |
| Volume | 77 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.97M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-7.97M | $-5.32 |
| 2024 | $0 | $-14.10M | $-0.87 |
| 2023 | $0 | $-14.58M | $-1.15 |
| 2022 | $0 | $-12.09M | $-1.12 |
3 analysts cover ACXP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.